Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

The current and future of immunotherapy for metastatic NSCLC

What’s next? Emerging next-generation immunotherapy in lung cancer

Date

12 Sep 2022

Session

The current and future of immunotherapy for metastatic NSCLC

Topics

Immunotherapy

Tumour Site

Presenters

Natasha Leighl

Authors

N. Leighl

Author affiliations

  • Medical Oncology Department, UHN - University Health Network - Princess Margaret Cancer Center, M5G 2M9 - Toronto/CA

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: The current and future of immunotherapy for metastatic NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.